Cabioglu, N. Et Al. 2022. AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03. San Antonio Breast Cancer Symposium , (San-Antonio, Northern Mariana Islands).

Cabioglu, N., KARANLIK, H., Gulcelik, M. A., Igci, A., Muslumanoglu, M., Kocer, H. B., ... Uras, C.(2022). AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03 . San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands

Cabioglu, Neslihan Et Al. "AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03," San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 2022

Cabioglu, Neslihan Et Al. "AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03." San Antonio Breast Cancer Symposium , San-Antonio, Northern Mariana Islands, 2022

Cabioglu, N. Et Al. (2022) . "AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03." San Antonio Breast Cancer Symposium , San-Antonio, Northern Mariana Islands.

@conferencepaper{conferencepaper, author={Neslihan Cabioglu Et Al. }, title={AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03}, congress name={San Antonio Breast Cancer Symposium}, city={San-Antonio}, country={Northern Mariana Islands}, year={2022}}